Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Old and New Beta-Lactamase Inhibitors: Molecular Structure, Mechanism of Action, and Clinical Use
Davide Carcione, Claudia Siracusa, Adela Sulejmani, et al.
Antibiotics (2021) Vol. 10, Iss. 8, pp. 995-995
Open Access | Times Cited: 61

Showing 1-25 of 61 citing articles:

Antibiotic Adjuvants: A Versatile Approach to Combat Antibiotic Resistance
Geetika Dhanda, Yash Acharya, Jayanta Haldar
ACS Omega (2023) Vol. 8, Iss. 12, pp. 10757-10783
Open Access | Times Cited: 84
Role of β-Lactamase Inhibitors as Potentiators in Antimicrobial Chemotherapy Targeting Gram-Negative Bacteria
Song Zhang, Xinyu Liao, Tian Ding, et al.
Antibiotics (2024) Vol. 13, Iss. 3, pp. 260-260
Open Access | Times Cited: 20
Boron-Containing heterocycles as promising pharmacological agents
Bhaskar C. Das, Mohd Adil Shareef, Sasmita Das, et al.
Bioorganic & Medicinal Chemistry (2022) Vol. 63, pp. 116748-116748
Closed Access | Times Cited: 54
β-Lactam Antibiotics and β-Lactamase Enzymes Inhibitors, Part 2: Our Limited Resources
Silvana Alfei, Anna Maria Schito
Pharmaceuticals (2022) Vol. 15, Iss. 4, pp. 476-476
Open Access | Times Cited: 40
Molecular Characterization of spa, hld, fmhA, and lukD Genes and Computational Modeling the Multidrug Resistance of Staphylococcus Species through Callindra harrisii Silver Nanoparticles
Muhammad Waseem, Muhammad Naveed, Shafiq ur Rehman, et al.
ACS Omega (2023) Vol. 8, Iss. 23, pp. 20920-20936
Open Access | Times Cited: 24
Municipal wastewater treatment plant showing a potential reservoir for clinically relevant MDR bacterial strains co-occurrence of ESBL genes and integron-integrase genes
Kuldeep Soni, David Kothamasi, Ram Chandra
Journal of Environmental Management (2024) Vol. 351, pp. 119938-119938
Closed Access | Times Cited: 12
Penicillin Derivatives Inhibit the SARS-CoV-2 Main Protease by Reaction with Its Nucleophilic Cysteine
Tika R. Malla, Lennart Brewitz, Dorian-Gabriel Muntean, et al.
Journal of Medicinal Chemistry (2022) Vol. 65, Iss. 11, pp. 7682-7696
Open Access | Times Cited: 31
Biochemical exploration of β-lactamase inhibitors
Varshaa Arer, Debasish Kar
Frontiers in Genetics (2023) Vol. 13
Open Access | Times Cited: 20
What are the optimal pharmacokinetic/pharmacodynamic targets for β-lactamase inhibitors? A systematic review
Getnet Mengistu Assefa, Jason A. Roberts, Solomon Ahmed Mohammed, et al.
Journal of Antimicrobial Chemotherapy (2024) Vol. 79, Iss. 5, pp. 946-958
Open Access | Times Cited: 7
Transient comparison of techniques to counter multi-drug resistant bacteria: prime modules in curation of bacterial infections
Muhammad Naveed, Muhammad Waseem, Izma Mahkdoom, et al.
Frontiers in Antibiotics (2024) Vol. 2
Open Access | Times Cited: 4
Antibacterial Potential of Crude Extracts from Cylindrospermum alatosporum NR125682 and Loriellopsis cavernicola NR117881
Albert Olufemi Ikhane, Foluso Oluwagbemiga Osunsanmi, Rebamang A. Mosa, et al.
Microorganisms (2025) Vol. 13, Iss. 1, pp. 211-211
Open Access
β-Lactam/β-Lactamase Inhibitor Combination Antibiotics Under Development
Angeliki Katsarou, Panagiotis Stathopoulos, Iva D. Tzvetanova, et al.
Pathogens (2025) Vol. 14, Iss. 2, pp. 168-168
Open Access
Nano‐Biocatalysis for Remediation of Pharmaceutical Micropollutants in Industrial Wastewaters
Darshankumar Prajapati, Ashish Bhatt, Ravi Kachhadiya, et al.
(2025), pp. 321-354
Closed Access
Recommendations to Synthetize Old and New β-Lactamases Inhibitors: A Review to Encourage Further Production
Silvana Alfei, Guendalina Zuccari
Pharmaceuticals (2022) Vol. 15, Iss. 3, pp. 384-384
Open Access | Times Cited: 18
Helicobacter Pylori: A Review of Current Treatment Options in Clinical Practice
Logan T Roberts, Peter P. Issa, Evan S. Sinnathamby, et al.
Life (2022) Vol. 12, Iss. 12, pp. 2038-2038
Open Access | Times Cited: 16
Antimicrobial Activity of Aztreonam in Combination with Old and New β-Lactamase Inhibitors against MBL and ESBL Co-Producing Gram-Negative Clinical Isolates: Possible Options for the Treatment of Complicated Infections
Gianluca Morroni, Raffaela Bressan, Simona Fioriti, et al.
Antibiotics (2021) Vol. 10, Iss. 11, pp. 1341-1341
Open Access | Times Cited: 21
In Vitro Mechanisms of Resistance Development to Imipenem-Relebactam in KPC-Producing Klebsiella pneumoniae
Jacqueline Findlay, Céline Rens, Laurent Poirel, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 10
Open Access | Times Cited: 14
Heavy Metal (Arsenic) Induced Antibiotic Resistance among Extended-Spectrum β-Lactamase (ESBL) Producing Bacteria of Nosocomial Origin
Naveed Ahmed, Kinza Tahir, Sara Aslam, et al.
Pharmaceuticals (2022) Vol. 15, Iss. 11, pp. 1426-1426
Open Access | Times Cited: 14
Coexistence of blaNDM-1 and blaIMP-4 in One Novel Hybrid Plasmid Confers Transferable Carbapenem Resistance in an ST20-K28 Klebsiella pneumoniae
Xinmiao Jia, Peiyao Jia, Ying Zhu, et al.
Frontiers in Microbiology (2022) Vol. 13
Open Access | Times Cited: 13
Evolutionary Trajectories toward High-Level β-Lactam/β-Lactamase Inhibitor Resistance in the Presence of Multiple β-Lactamases
Fredrika Rajer, Lisa Allander, Philip A. Karlsson, et al.
Antimicrobial Agents and Chemotherapy (2022) Vol. 66, Iss. 6
Open Access | Times Cited: 12
Development and Evaluation of Novel Amoxicillin and Phytic Acid-Loaded Gastro-Retentive Mucoadhesive Pectin Microparticles for the Management of Helicobacter pylori Infections
Ajit Mishra, Debalina Maity, Deepak Pradhan, et al.
Journal of Pharmaceutical Innovation (2024) Vol. 19, Iss. 2
Closed Access | Times Cited: 2
Cefoperazone-Sulbactam-Induced Coagulopathy in Critically Ill Egyptian Patients: Role of Vitamin K Prophylactic Doses
Abdel-Hameed Ebid, Hebatallah Ali Abdeen, Rabab Maher, et al.
Hospital Pharmacy (2024) Vol. 59, Iss. 5, pp. 575-583
Closed Access | Times Cited: 2
Metallo-β-lactamase inhibitors: A continuing challenge for combating antibiotic resistance
Su‐Jin Kang, Do‐Hee Kim, Bong‐Jin Lee
Biophysical Chemistry (2024) Vol. 309, pp. 107228-107228
Closed Access | Times Cited: 2
Mechanism-guided strategies for combating antibiotic resistance
Shengwei Sun, Xueyingzi Chen
World Journal of Microbiology and Biotechnology (2024) Vol. 40, Iss. 10
Closed Access | Times Cited: 2
Extended-spectrum β-lactamase-producing Escherichia coli from poultry: A review
Agus Widodo, Aswin Rafif Khairullah, Mustofa Helmi Effendi, et al.
Veterinary World (2024), pp. 2017-2027
Open Access | Times Cited: 2
Page 1 - Next Page

Scroll to top